Xolair (omalizumab) - Roche, Novartis
Cosentyx (secukinumab) - Novartis
Dupixent (dupilumab) - Sanofi, Regeneron
http://www.ncbi.nlm.nih.gov/pubmed/42769850
 
Aikaterini Kyriakou; Aikaterini Patsatsi; Anastasia Tsitlakidou; Antonios Fantakis; Athanasia Tsaousi; Athina-Ioanna Daponte; Christos Minas; Elisavet Lazaridou; Maria-Emmanouela Anagnostaki; Parthena Meltzanidou
 
Sep 23, 2026
 
Prev Next